Annual CFI
-$8.13 M
-$5.92 M-267.89%
31 December 2023
Summary:
Armata Pharmaceuticals annual cash flow from investing activities is currently -$8.13 million, with the most recent change of -$5.92 million (-267.89%) on 31 December 2023. During the last 3 years, it has fallen by -$7.31 million (-887.14%). ARMP annual CFI is now -176.74% below its all-time high of $10.60 million, reached on 31 December 1997.ARMP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$340.00 K
+$1.03 M+75.11%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly cash flow from investing activities is currently -$340.00 thousand, with the most recent change of +$1.03 million (+75.11%) on 30 September 2024. Over the past year, it has increased by +$3.17 million (+90.32%). ARMP quarterly CFI is now -103.62% below its all-time high of $9.38 million, reached on 30 September 2018.ARMP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$4.35 M
+$3.17 M+42.19%
30 September 2024
Summary:
Armata Pharmaceuticals TTM cash flow from investing activities is currently -$4.35 million, with the most recent change of +$3.17 million (+42.19%) on 30 September 2024. Over the past year, it has increased by +$943.00 thousand (+17.83%). ARMP TTM CFI is now -133.69% below its all-time high of $12.90 million, reached on 31 March 1998.ARMP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -267.9% | +90.3% | +17.8% |
| 3 y3 years | -887.1% | +41.6% | -201.4% |
| 5 y5 years | -10000.0% | -623.1% | +34.0% |
ARMP Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -887.1% | at low | -174.7% | +90.3% | -249.9% | +46.6% |
| 5 y | 5 years | -382.7% | at low | -174.7% | +90.3% | -249.1% | +46.6% |
| alltime | all time | -176.7% | at low | -103.6% | +96.4% | -133.7% | +56.1% |
Armata Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$340.00 K(-75.1%) | -$4.35 M(-42.2%) |
| June 2024 | - | -$1.37 M(+446.4%) | -$7.52 M(+17.9%) |
| Mar 2024 | - | -$250.00 K(-89.5%) | -$6.37 M(-21.6%) |
| Dec 2023 | -$8.13 M(+267.9%) | -$2.39 M(-31.9%) | -$8.13 M(+53.8%) |
| Sept 2023 | - | -$3.51 M(+1482.0%) | -$5.29 M(+72.2%) |
| June 2023 | - | -$222.00 K(-89.0%) | -$3.07 M(-22.9%) |
| Mar 2023 | - | -$2.01 M(-541.8%) | -$3.98 M(+80.2%) |
| Dec 2022 | -$2.21 M(+69.6%) | $455.00 K(-135.2%) | -$2.21 M(-23.6%) |
| Sept 2022 | - | -$1.29 M(+13.9%) | -$2.89 M(+32.6%) |
| June 2022 | - | -$1.14 M(+381.4%) | -$2.18 M(+75.7%) |
| Mar 2022 | - | -$236.00 K(+3.5%) | -$1.24 M(-4.8%) |
| Dec 2021 | -$1.30 M(+58.3%) | -$228.00 K(-60.8%) | -$1.30 M(-9.6%) |
| Sept 2021 | - | -$582.00 K(+196.9%) | -$1.44 M(+53.2%) |
| June 2021 | - | -$196.00 K(-34.2%) | -$941.00 K(-7.6%) |
| Mar 2021 | - | -$298.00 K(-18.6%) | -$1.02 M(+23.5%) |
| Dec 2020 | -$824.00 K(-128.6%) | -$366.00 K(+351.9%) | -$824.00 K(+113.5%) |
| Sept 2020 | - | -$81.00 K(-70.3%) | -$386.00 K(+60.8%) |
| June 2020 | - | -$273.00 K(+162.5%) | -$240.00 K(-108.2%) |
| Mar 2020 | - | -$104.00 K(-244.4%) | $2.92 M(+1.3%) |
| Dec 2019 | $2.88 M(-6638.6%) | $72.00 K(+10.8%) | $2.88 M(-143.7%) |
| Sept 2019 | - | $65.00 K(-97.7%) | -$6.59 M(-341.6%) |
| June 2019 | - | $2.88 M(-2129.6%) | $2.73 M(-1566.1%) |
| Mar 2019 | - | -$142.00 K(-98.5%) | -$186.00 K(+322.7%) |
| Dec 2018 | -$44.00 K(-24.1%) | -$9.39 M(-200.1%) | -$44.00 K(-100.5%) |
| Sept 2018 | - | $9.38 M(<-9900.0%) | $9.33 M(<-9900.0%) |
| June 2018 | - | -$31.00 K(<-9900.0%) | -$82.00 K(+54.7%) |
| Mar 2018 | - | $0.00(-100.0%) | -$53.00 K(-8.6%) |
| Dec 2017 | -$58.00 K(-79.2%) | -$18.00 K(-45.5%) | -$58.00 K(+9.4%) |
| Sept 2017 | - | -$33.00 K(+1550.0%) | -$53.00 K(+8.2%) |
| June 2017 | - | -$2000.00(-60.0%) | -$49.00 K(-71.5%) |
| Mar 2017 | - | -$5000.00(-61.5%) | -$172.00 K(-38.4%) |
| Dec 2016 | -$279.00 K(+32.9%) | -$13.00 K(-55.2%) | -$279.00 K(-11.7%) |
| Sept 2016 | - | -$29.00 K(-76.8%) | -$316.00 K(-21.6%) |
| June 2016 | - | -$125.00 K(+11.6%) | -$403.00 K(+40.4%) |
| Mar 2016 | - | -$112.00 K(+124.0%) | -$287.00 K(+36.7%) |
| Dec 2015 | -$210.00 K(-82.5%) | -$50.00 K(-56.9%) | -$210.00 K(+27.3%) |
| Sept 2015 | - | -$116.00 K(+1188.9%) | -$165.00 K(-11.3%) |
| June 2015 | - | -$9000.00(-74.3%) | -$186.00 K(-81.5%) |
| Mar 2015 | - | -$35.00 K(+600.0%) | -$1.01 M(-16.1%) |
| Dec 2014 | -$1.20 M(+1078.4%) | -$5000.00(-96.4%) | -$1.20 M(0.0%) |
| Sept 2014 | - | -$137.00 K(-83.5%) | -$1.20 M(+9.6%) |
| June 2014 | - | -$831.00 K(+262.9%) | -$1.10 M(+231.4%) |
| Mar 2014 | - | -$229.00 K(+4480.0%) | -$331.00 K(+224.5%) |
| Dec 2013 | -$102.00 K(-103.3%) | -$5000.00(-84.4%) | -$102.00 K(+5.2%) |
| Sept 2013 | - | -$32.00 K(-50.8%) | -$97.00 K(+49.2%) |
| June 2013 | - | -$65.00 K(<-9900.0%) | -$65.00 K(<-9900.0%) |
| Mar 2013 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2012 | $3.10 M(-567.8%) | - | - |
| Sept 2009 | - | $258.00 K(-5260.0%) | $148.00 K(-203.5%) |
| June 2009 | - | -$5000.00(-16.7%) | -$143.00 K(-77.4%) |
| Mar 2009 | - | -$6000.00(-93.9%) | -$634.00 K(-4.2%) |
| Dec 2008 | -$662.00 K | -$99.00 K(+200.0%) | -$662.00 K(-15.3%) |
| Sept 2008 | - | -$33.00 K(-93.3%) | -$782.00 K(-4.3%) |
| June 2008 | - | -$496.00 K(+1358.8%) | -$817.00 K(+44.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$34.00 K(-84.5%) | -$564.00 K(+9.7%) |
| Dec 2007 | -$514.00 K(+1506.3%) | -$219.00 K(+222.1%) | -$514.00 K(+69.1%) |
| Sept 2007 | - | -$68.00 K(-72.0%) | -$304.00 K(+21.1%) |
| June 2007 | - | -$243.00 K(-1618.8%) | -$251.00 K(+1155.0%) |
| Mar 2007 | - | $16.00 K(-277.8%) | -$20.00 K(-37.5%) |
| Dec 2006 | -$32.00 K(-94.8%) | -$9000.00(-40.0%) | -$32.00 K(-49.2%) |
| Sept 2006 | - | -$15.00 K(+25.0%) | -$63.00 K(-81.8%) |
| June 2006 | - | -$12.00 K(-400.0%) | -$347.00 K(-18.9%) |
| Mar 2006 | - | $4000.00(-110.0%) | -$428.00 K(-30.1%) |
| Dec 2005 | -$612.00 K(+50.0%) | -$40.00 K(-86.6%) | -$612.00 K(-3.5%) |
| Sept 2005 | - | -$299.00 K(+221.5%) | -$634.00 K(+16.5%) |
| June 2005 | - | -$93.00 K(-48.3%) | -$544.00 K(+7.9%) |
| Mar 2005 | - | -$180.00 K(+190.3%) | -$504.00 K(+23.5%) |
| Dec 2004 | -$408.00 K(+29.1%) | -$62.00 K(-70.3%) | -$408.00 K(-20.5%) |
| Sept 2004 | - | -$209.00 K(+294.3%) | -$513.00 K(+53.1%) |
| June 2004 | - | -$53.00 K(-36.9%) | -$335.00 K(-9.0%) |
| Mar 2004 | - | -$84.00 K(-49.7%) | -$368.00 K(+16.5%) |
| Dec 2003 | -$316.00 K(-87.3%) | -$167.00 K(+438.7%) | -$316.00 K(-191.1%) |
| Sept 2003 | - | -$31.00 K(-64.0%) | $347.00 K(-170.8%) |
| June 2003 | - | -$86.00 K(+168.8%) | -$490.00 K(-24.5%) |
| Mar 2003 | - | -$32.00 K(-106.5%) | -$649.00 K(-73.9%) |
| Dec 2002 | -$2.49 M(-65.5%) | $496.00 K(-157.1%) | -$2.49 M(-28.7%) |
| Sept 2002 | - | -$868.00 K(+254.3%) | -$3.49 M(+1.1%) |
| June 2002 | - | -$245.00 K(-86.9%) | -$3.45 M(-53.3%) |
| Mar 2002 | - | -$1.87 M(+269.9%) | -$7.39 M(+2.4%) |
| Dec 2001 | -$7.22 M(+224.9%) | -$506.10 K(-39.0%) | -$7.22 M(-22.9%) |
| Sept 2001 | - | -$829.10 K(-80.2%) | -$9.36 M(+16.1%) |
| June 2001 | - | -$4.18 M(+145.8%) | -$8.06 M(+168.2%) |
| Mar 2001 | - | -$1.70 M(-35.8%) | -$3.01 M(+35.3%) |
| Dec 2000 | -$2.22 M(-143.5%) | -$2.65 M(-664.2%) | -$2.22 M(-519.5%) |
| Sept 2000 | - | $469.80 K(-46.3%) | $529.50 K(-255.6%) |
| June 2000 | - | $875.60 K(-195.6%) | -$340.30 K(-112.2%) |
| Mar 2000 | - | -$915.90 K(-1015.9%) | $2.78 M(-45.4%) |
| Dec 1999 | $5.10 M(-182.3%) | $100.00 K(-125.0%) | $5.10 M(+410.0%) |
| Sept 1999 | - | -$400.00 K(-110.0%) | $1.00 M(-79.2%) |
| June 1999 | - | $4.00 M(+185.7%) | $4.80 M(-164.9%) |
| Mar 1999 | - | $1.40 M(-135.0%) | -$7.40 M(+19.4%) |
| Dec 1998 | -$6.20 M(-158.5%) | -$4.00 M(-217.6%) | -$6.20 M(+1450.0%) |
| Sept 1998 | - | $3.40 M(-141.5%) | -$400.00 K(-122.2%) |
| June 1998 | - | -$8.20 M(-415.4%) | $1.80 M(-86.0%) |
| Mar 1998 | - | $2.60 M(+44.4%) | $12.90 M(+21.7%) |
| Dec 1997 | $10.60 M(-421.2%) | $1.80 M(-67.9%) | $10.60 M(-16.5%) |
| Sept 1997 | - | $5.60 M(+93.1%) | $12.70 M(+370.4%) |
| June 1997 | - | $2.90 M(+866.7%) | $2.70 M(-162.8%) |
| Mar 1997 | - | $300.00 K(-92.3%) | -$4.30 M(+30.3%) |
| Dec 1996 | -$3.30 M(-23.3%) | $3.90 M(-188.6%) | -$3.30 M(-51.5%) |
| Sept 1996 | - | -$4.40 M(+7.3%) | -$6.80 M(-31.3%) |
| June 1996 | - | -$4.10 M(-415.4%) | -$9.90 M(+175.0%) |
| Mar 1996 | - | $1.30 M(+225.0%) | -$3.60 M(-16.3%) |
| Dec 1995 | -$4.30 M(-8.5%) | $400.00 K(-105.3%) | -$4.30 M(-8.5%) |
| Sept 1995 | - | -$7.50 M(-440.9%) | -$4.70 M(-267.9%) |
| June 1995 | - | $2.20 M(+266.7%) | $2.80 M(+366.7%) |
| Mar 1995 | - | $600.00 K | $600.00 K |
| Dec 1994 | -$4.70 M(-1040.0%) | - | - |
| Dec 1993 | $500.00 K | - | - |
FAQ
- What is Armata Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual CFI year-on-year change?
- What is Armata Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly CFI year-on-year change?
- What is Armata Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals TTM CFI year-on-year change?
What is Armata Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ARMP is -$8.13 M
What is the all time high annual CFI for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual cash flow from investing activities is $10.60 M
What is Armata Pharmaceuticals annual CFI year-on-year change?
Over the past year, ARMP annual cash flow from investing activities has changed by -$5.92 M (-267.89%)
What is Armata Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ARMP is -$340.00 K
What is the all time high quarterly CFI for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly cash flow from investing activities is $9.38 M
What is Armata Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ARMP quarterly cash flow from investing activities has changed by +$3.17 M (+90.32%)
What is Armata Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ARMP is -$4.35 M
What is the all time high TTM CFI for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high TTM cash flow from investing activities is $12.90 M
What is Armata Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ARMP TTM cash flow from investing activities has changed by +$943.00 K (+17.83%)